novonordisk.com
Growth Hormone Therapy
http://www.novonordisk.com/health-care-professionals/growth-hormone-therapy.html
Insulin Pens and Needles. Disease Areas - Introduction. Is my child growing normally? What is growth hormone? Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin. Haemophilia is an inherited (congenital) bleeding disorder that affects males. Growth Hormone is crucial to the healthy development and functioning of the human body. HRT is used to treat climacteric symptoms of women in different stages of the menopause. Working at Novo Nordisk. Elev i Novo Nordisk.
novonordiskpro.co.uk
Login
https://www.novonordiskpro.co.uk/home.html
Like most websites, Novo Nordisk Pro uses cookies. We use cookies to verify that only registered healthcare professionals are allowed access to promotional content on prescription medicines, to deliver more relevant content and for performance analysis. It is not possible to use this site without accepting that we may store and access cookies on your device. By using this site, you agree to these terms. Please see our Privacy policy. For more information on our use of cookies and how to reject them.
novonordisk.com
Insulin Pens and Needles
http://www.novonordisk.com/patients/diabetes-care/insulin-pens-and-needles.html
Insulin Pens and Needles. Disease Areas - Introduction. Is my child growing normally? What is growth hormone? Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin. Haemophilia is an inherited (congenital) bleeding disorder that affects males. Growth Hormone is crucial to the healthy development and functioning of the human body. HRT is used to treat climacteric symptoms of women in different stages of the menopause. Working at Novo Nordisk. Elev i Novo Nordisk.
novologpro.com
NovoLog® Insulin Pen Options
https://www.novologpro.com/prescribing/insulin-pens.html
Non-US Health Care Professionals. Insulin aspart (rDNA origin) injection. For US Health Care Professionals Only. Is available in multiple pen devices, designed and engineered to best meet the needs of your patients. Pre-filled, disposable insulin pen for discreet mealtime management on the go. A durable insulin pen with memory function, smaller half-unit dosing, and fun colorful skins. Is also available in a vial or for pump use. Selected Important Safety Information. Or one of its excipients. Insulin as...
novologpro.com
NovoLog® Clinical Studies | NovoLog® (Insulin Aspart)
https://www.novologpro.com/resources/clinical-studies.html
Non-US Health Care Professionals. Insulin aspart (rDNA origin) injection. For US Health Care Professionals Only. The links below will provide you access to the published clinical data on PubMed.gov. The website of the US National Library of Medicine, National Institutes of Health. Rodbard et al 2014. Rodbard et al 2014. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial.
saxendapro.com
Resources for Your Patients | SaxendaCare®
https://www.saxendapro.com/patient-resources.html
Non-US Health Care Professionals. Liraglutide [rDNA origin] injection). For US Health Care Professionals Only. Secondary Efficacy End Points. Target=" self" Appropriate Patients for Saxenda. Target=" self" Prescribing Saxenda. Target=" self" Administering Saxenda. Having the Injection Conversation. Patient Savings and Support. Patient Savings and Support. For chronic weight management in adult patients with a BMI. Pen and dose-escalation training. Dosing and refill reminders. Causes thyroid C-cell tumors...
saxendapro.com
Dosing and Administration of Saxenda® | Saxenda® Patients
https://www.saxendapro.com/Dosing-and-Administration.html
Non-US Health Care Professionals. Liraglutide [rDNA origin] injection). For US Health Care Professionals Only. Secondary Efficacy End Points. Target=" self" Appropriate Patients for Saxenda. Target=" self" Prescribing Saxenda. Target=" self" Administering Saxenda. Having the Injection Conversation. Patient Savings and Support. Appropriate Patients for Saxenda. For chronic weight management in adult patients with a BMI. You may have patients who are right for Saxenda. Seeking other treatment options.
victozapro.com
Video Library | Victoza® (liraglutide) injection 1.2 mg or 1.8 mg
https://www.victozapro.com/resources-and-samples/patient-testimonials.html
Non-US Health Care Professionals. Liraglutide) injection 1.2 mg or 1.8 mg. For US Health Care Professionals Only. A1C Reductions Across Studies. Once-Daily vs Once-Weekly GLP-1 Receptor Agonists. Low Rates of Hypoglycemia. Request Samples on NovoMedLink. Patient Programs and Resources. Co-Pay and Prior Authorization Tools. Watch these videos to find out how Victoza. Can help your patients. See the effects of Victoza. Find out how to start the conversation about Victoza. Pen Instructions for First-Time Use.
victozapro.com
VictozaCareTM | Victoza® (liraglutide) injection 1.2 mg or 1.8 mg
https://www.victozapro.com/resources-and-samples/for-your-patients.html
Non-US Health Care Professionals. Liraglutide) injection 1.2 mg or 1.8 mg. For US Health Care Professionals Only. A1C Reductions Across Studies. Once-Daily vs Once-Weekly GLP-1 Receptor Agonists. Low Rates of Hypoglycemia. Request Samples on NovoMedLink. Patient Programs and Resources. Co-Pay and Prior Authorization Tools. Patient Programs and Resources. Added support for your adult patients with type 2 diabetes. Patients enrolled in VictozaCare were more adherent than those not enrolled. This online coa...
victozapro.com
Reducing A1C Levels | Victoza® (liraglutide) injection 1.2 mg or 1.8 mg
https://www.victozapro.com/clinical-benefits/early-and-lasting-a1c-reductions.html
Non-US Health Care Professionals. Liraglutide) injection 1.2 mg or 1.8 mg. For US Health Care Professionals Only. A1C Reductions Across Studies. Once-Daily vs Once-Weekly GLP-1 Receptor Agonists. Low Rates of Hypoglycemia. Request Samples on NovoMedLink. Patient Programs and Resources. Co-Pay and Prior Authorization Tools. A1C Reductions Across Studies. Is unsurpassed in reducing A1C across these multiple studies in adults with type 2 diabetes. Mean change in A1C (%). LEAD 4 vs metformin TZD. SU vs TZD SU.